EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 383 filers reported holding EXELIXIS INC in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $176 | -100.0% | 10,953 | -54.1% | 0.02% | -32.4% |
Q3 2022 | $374,000 | -20.8% | 23,849 | +5.3% | 0.03% | -15.0% |
Q2 2022 | $472,000 | +36.0% | 22,657 | +31.0% | 0.04% | +8.1% |
Q4 2020 | $347,000 | +24.8% | 17,300 | +9.5% | 0.04% | +37.0% |
Q4 2019 | $278,000 | -71.6% | 15,800 | -71.5% | 0.03% | -64.5% |
Q3 2019 | $979,000 | +71.8% | 55,353 | +107.5% | 0.08% | +130.3% |
Q2 2019 | $570,000 | +102.1% | 26,672 | +124.8% | 0.03% | +106.2% |
Q1 2019 | $282,000 | -79.7% | 11,865 | -81.1% | 0.02% | -78.7% |
Q1 2018 | $1,391,000 | +2923.9% | 62,817 | +411.0% | 0.08% | +1775.0% |
Q2 2015 | $46,000 | – | 12,293 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |